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Objectives: Falls and neuropsychiatric symptoms (NPS) are common among long-term care27
residents with cognitive impairment. Despite the high prevalence of both falls and NPS, little is28
known about their association. The aim of our study was to explore how NPS, particularly the29
severity of NPS and specific NPS subgroups, are associated with falls and how psychotropics30
modify this association.31
Design: Longitudinal cohort study.32
Setting and Participants: 532 long-term care residents aged 65 years or over in Helsinki, Finland.33
Methods: NPS were measured with Neuropsychiatric Inventory (NPI) at baseline. Participants were34
grouped into three groups: no significant NPS (NPI points 0-3), low NPS burden (NPI 4-12) and35
high NPS burden (NPI>12). The number of falls, injuries, fractures, and hospitalizations were36
collected from medical records over 12 months following baseline assessment.37
Results: Altogether 606 falls occurred during the follow-up year. The falls led to 121 injuries, 4238
hospitalizations, and 20 fractures. Falls and injuries increased significantly with NPS burden39
(p<0.001): 330 falls in the high NPS group (n=184), 188 falls in the low NPS group (n=181) and 8840
falls in the no significant NPS group (n=167). The risk of falling showed a curvilinear association41
with NPI total score. Of NPS subgroups, psychosis and hyperactivity were associated with a higher42
incidence rate ratio of falls, whereas apathy had a protective association even after adjustment for43
age, sex and mobility. Affective symptoms were not associated with falls. Psychotropics did not44
modify the association between NPS burden and falls.45
Conclusions and Implications: The results of this study show that NPS, especially NPS severity,46
may predict falls and fall-related negative consequences. Severity of NPS should be taken into47
account when assessing fall risk in long-term care residents with cognitive impairment.48




Falls and fall-related negative consequences among long-term care residents with cognitive52
impairment are common.1-4 An estimated 37-65% of older people with cognitive impairment or53
dementia fall annually.5-6 The risk factors for falls are multiple and seem to vary between54
community- and institution-dwelling older adults with cognitive impairment.3, 6-7 Impaired mobility,55
use of psychotropic drugs, anxiety, depression and orthostatic hypotension have been shown to56
increase fall risk.4, 7-1257
Neuropsychiatric symptoms (NPS), also called behavioral and psychological symptoms of dementia58
(BPSD), are known to be highly common in cognitive impairment, especially in long-term care59
settings. The prevalence of NPS in long-term care has been estimated to be as high as 82-92%.13-1460
NPS include such symptoms as agitation, apathy, anxiety, aberrant motor behavior, delusions,61
dysphoria, disinhibition, euphoria, hallucinations, and irritability.15 Cluster analyses have identified62
four NPS subgroups: hyperactivity, psychosis, affective symptoms, and apathy.1663
Despite the high prevalence of both NPS and falls among older adults with cognitive impairment in64
long-term care, little is known about the association between NPS and falls. A few studies have65
suggested NPS to be an independent risk factor for falls.17-22 However, it is not known whether66
severity of NPS has an impact on fall rate. Thus, the aim of our study was to explore how NPS, and67
more specifically the severity of NPS, are associated with falls and their consequences. Another aim68
was to determine how specific NPS subgroups impact the incidence of falls.69
Methods70
Study participants71
Participants were recruited to this longitudinal cohort study from institutional settings in Helsinki in72
2017. From a random sample from 18 nursing homes, 544 volunteer residents were recruited to this73
study. Participants’ baseline assessment occurred between February 2018 and August 2018. All74
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participants who completed the Neuropsychiatric Inventory (NPI) at baseline (n=532) were75
included in the study. The participants were followed for 12 months or until death.76
77
Measures78
Study nurses were trained to perform the assessments. One of the researchers (HMR) participated in79
and supported the nurses in the baseline assessments and data collection. Data on demographic80
factors such as age, sex, and diagnoses, were collected from medical records. The study nurses81
calculated the Charlson Comorbidity Index23 to assess each resident’s burden of comorbidity and82
the Barthel Index24 for functional evaluation. Mobility was assessed by the 15D questionnaire2583
item on mobility and categorized into one of the following: 1) “able to walk without help outdoors84
or indoors”, 2) “able to walk indoors only with help from others”, or 3) “completely bed-ridden and85
unable to move about.” Mini Mental State Examination (MMSE)26 and Clinical Dementia Rating86
(CDR)27 were performed to assess the severity of cognitive impairment. Presence of vision and87
hearing deficits were assessed by 15D questionnaire25 items on vision and hearing. Vision was88
categorized into either 1) “able to read papers and/or TV text with or without glasses” or 2) “not89
able to read papers or TV text either with glasses or without. Hearing was categorized into either 1)90
“able to hear speech with or without a hearing aid with normal or louder than normal voice or 2)91
“able to hear even loud voices poorly or deaf”.92
Data on medication use were retrieved from medical records on the assessment day. All93
medications were classified using the Anatomical Therapeutic Chemical (ATC) classification94
system.28 Psychotropic medications included antipsychotics (N05A), antidepressants (N06A),95
anxiolytics (N05B), and hypnotics and sedatives (N05C). The use of Alzheimer medication (N06D)96
included cholinesterase inhibitors (N06DA) and/or memantine (N06DX01). Only regularly used97
medications were considered. Medication use was considered regular if there was a documented98
regular sequence of administration.99
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To evaluate NPS, study nurses interviewed care staff from the long-term care units using the NPI.29100
The NPI was chosen instead of NPI-NH, because the nursing home version has not been translated101
to Finnish language. The content of the questions of the NPI and NPI-NH are identical. NPI102
includes 10 different NPS (agitation, apathy, anxiety, aberrant motor behavior, delusions,103
dysphoria, disinhibition, euphoria, hallucinations, irritability). For each symptom, the severity is104
multiplied by the frequency, and the sum score provides the total NPI score (range 0 to 120).105
Subgroups of “Psychosis” (delusion, hallucinations), “Hyperactivity” (agitation, euphoria,106
disinhibition, irritability, aberrant motor behavior), “Affective symptoms” (depression, anxiety),107
and “Apathy” (apathy) were calculated separately, as earlier described16. We grouped the residents108
according to the total score on NPI into three groups: no significant NPS (NPI 0-3), low NPS109
burden (NPI 4-12), and high NPS burden (NPI >12). According to previous studies, a score >3 is110
taken to indicate the presence of clinically relevant symptoms.29 The cut-off point of 12 was chosen111
as it was the median. In previous studies a total NPI score greater than 11 points arising from at112
least three domains has been considered to indicate marked neuropsychiatric symptoms.30 After113
baseline assessment, data regarding falls (number of falls, injuries, fractures, and hospitalizations)114





Data are presented as means with standard deviation (SD) or as counts with percentages. The120
statistical significance for the unadjusted hypothesis of linearity across categories (tertiles) of NPI121
total score and characteristics of study participants was evaluated using the Cochran-Armitage test122
for trend, analysis of variance (ANOVA), and logistic (ordinal) models with an appropriate contrast.123
A bootstrap method was used when the theoretical distribution of the test statistics was unknown or124
in case of violation of assumptions (e.g. non-normality). We used the Kaplan-Meier method to125
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construct estimated mortality. Cox proportional Hazard Model was used to estimate age, sex and126
mobility adjusted risk (HR) for mortality between the groups. The number and incidence rate of127
falls were calculated assuming a Poisson distribution. Adjusted incidence rate and incidence rate128
ratio (IRR) were calculated using a Poisson regression model that included sex, age and mobility as129
covariates. Multivariate Poisson regression models with forward stepwise was used to investigate130
factors related to incidence of falls. Variables significant at the P<0.10 level in unadjusted analyses131
were included into the model. Multivariate Poisson regression was tested using goodness of fit of132
the model, and the assumption of overdispersion in the Poisson model was tested using the133
Lagrange multiplier test. A possible non-linear relationship between all falls and the NPI total score134
was assessed by using a 3-knot-restricted cubic (placed according to Harrell’s recommended135
percentiles) spline Poisson regression model. The normality of variables was evaluated graphically136





The study protocol was approved by the Ethics Committee of the University of Helsinki. Written142
informed consent was obtained from each participant and in case of significant cognitive decline143
(CDR 2 or 3) from their closest proxy.144
145
Results146
The three NPI groups were similar in baseline demographic characteristics such as age, sex and147
Charlson Comorbidity Index (Table 1).  Residents’ mean age was 85 years, 80% were women and148
the mean number of comorbidities according to the Charlson Comorbidity Index was 2.1.149
Significant differences between the groups were detected in functional capacity according to the150
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Barthel Index and in mobility. The residents with the highest NPS burden were the most mobile and151
had better functioning than residents with no significant NPS (p<0.001). Two of three residents152
suffered from severe cognitive impairment (CDR 3) and the mean MMSE was low, 6.8. No153
significant differences existed between groups in severity of cognitive impairment according to154
MMSE (p=0.89) or CDR rating (p=0.35).155
The NPI groups differed significantly in psychotropic medication use (p<0.001). Mean number of156
psychotropic medications in the high NPS burden group was 2.3, compared with 1.8 in the group157
with no significant NPS. The proportion of residents taking any psychotropic medication was very158
high, 87%. Residents with high NPS burden were also administered more often Alzheimer’s159
medication (p=0.041) and had a higher number of total medications 8.8, compared with 7.9 in the160
group with no significant NPS (p=0.031). The most common NPS subgroup was hyperactivity in all161
NPI groups.162
163
Mortality and incidence of falls according to NPI total score during follow-up164
Total follow-up time was 446.8 person-years, with the mean time being 0.84 (range 0.01 – 1.00)165
years per person. During the one-year follow-up the mortality was 28.7% in the group with no166
significant NPS, 33.2% in the low NPS burden group, and 33.7% in the high NPS burden group167
(p=0.56). When the NPI 0-3 group was used as reference age, sex and mobility adjusted HR for168
mortality in NPI 4-12 group was 1.08 (95% CI 0.73 – 1.60) and in NPI >12 group 1.19 (95% CI169
0.80 – 1.79).170
Altogether 606 falls occurred during the follow-up: 330 in the high NPS burden group, 188 in the171
low NPS burden group and 88 in the no NPS group (Table 2). Of 532 residents, one-third fell at172
least once (94 residents). Severity of NPS measured by NPI total score had a curvilinear association173
with the incidence rate of falls per person years (Figure 1). Using the no significant NPS group as a174
reference, the low NPS burden group had an IRR per SD for falls of 1.64 (95% CI 1.27 – 2.12,175
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adjusted for age, sex and mobility), whereas in the high NPS burden group the IRR per SD was 2.43176
(95% Cl 1.91 – 3.08, adjusted for age, sex and mobility) (p for linearity < 0.001).177
The associations between NPS subgroups and the IRRs of falls and fall-related negative178
consequences are presented in Figure 2. Psychosis and Hyperactivity subgroups were associated179
with a higher IRR of falls and injuries, whereas Apathy showed a protective association against falls180
but not injuries. Affective symptoms did not predict falls nor injuries. Psychosis, Hyperactivity and181
Affective symptom subgroups were associated with a higher IRR of hospitalizations, whereas182
Apathy was not. None of the subgroups predicted fractures (Figure 2).183
Falls and fall-related negative consequences during the 12-month follow-up184
Of 606 falls, 121 led to injuries, 42 to injuries needing hospitalization, and 20 to fractures. Falls and185
injuries increased significantly with NPS burden (p<0.001). Residents with a higher NPI total score186
were also more often hospitalized for their falls than residents with no significant NPS or with a low187
NPS burden (p=0.002). The number of fractures increased in the higher NPI groups but it did not188
reach statistical significance (p=0.16) (Table 2).189
In a multivariate poisson regression analysis a higher NPI level (“NPI 4-12” IRR 1.72, 95% Cl 1.33190
to 2.23; “NPI >12” IRR 2.58, 95% Cl 2.03 to 3.29) and male gender (IRR 1.80, 95% Cl 1.51 to191
2.16) were associated with a higher incidence of falls. Worse mobility (“able to walk only with192
help” IRR 0.57, 95% Cl 0.47 to 0.69; ”bed-ridden” IRR 0.10, 95% Cl 0.07 to 0.15), age (IRR 0.98,193
95% Cl 0.97 to 0.99) and the use of psychotropic medication (IRR 0.88, 95% Cl 0.83 to 0.94) were194
associated with a lower incidence of falls. Alzheimer’s medication (IRR 1.12, 95% CI 0.94 to 1.33)195
and hearing decifits (IRR 0.76, 95% CI 0.45 to 1.26) were not associated with incidence of falls196
(Table 3).197
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Finally, we stratified the residents according to their psychotropic use to see how psychotropics198
modified the association between NPS severity and incidence rate of falls. NPI level was associated199
with incidence rate of falls per person-years (p<0.001 for NPI level), whereas psychotropic drug use200
did not have a significant association (p=0.94 for psychotropic), and no interaction existed (p=0.57201
for interaction) (Figure 3).202
Discussion203
NPI total score of long-term care residents with cognitive impairment showed a curvilinear204
association with the incidence rate of falls, indicating that severity of NPS is associated with risk of205
falls. Even after adjustments, IRR per SD in the high NPS burden group was nearly 2.5-fold that in206
the no significant NPS group. Psychotropic drug use did not modify this association. Another207
important finding was that, of all the NPS subgroups, specifically Psychosis and Hyperactivity had208
the highest association with fall rate, while Apathy seemed to have a protective association.209
The results of this study are in line with the few previous reports examining the association between210
NPS and falls.17-22 According to our study, the fall risk related to NPS seems to particularly arise211
from hyperactivity and psychotic symptoms. A population-based study from Sweden in 2005 also212
found that having hyperactive symptoms was one of the factors most strongly associated with falls.1213
The results from earlier studies regarding wandering are contradictory. A systematic review from214
2013 found wandering to be protective against falls3, whereas more recent studies have suggested215
that wandering increases the risk for falls.22, 31 In our study, affective symptoms and apathy were216
not associated with an increased fall risk. This could be due to less day-time activity offering less217
opportunities for falling.218
The findings from previous studies indicate that both NPS and falls increase with the severity of219
cognitive impairment.32-35 In our study, there was no difference in the severity of cognitive220
impairment between the three NPI groups measured by MMSE or CDR. This could be due to the221
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characteristics of our study population, with cognitive impairment being severe in all three groups.222
The NPI group with no significant NPS had the largest proportion of bed-ridden residents. An223
interesting finding was that the residents with the highest NPS burden at baseline also had the best224
mobility and the highest number of falls. This seems logical as these residents are physically more225
active during the day, thus having more opportunities to fall.  This is in line with earlier research on226
fall risk in long-term care.20 However, even after adjustment for mobility, the severity of NPS227
remained significantly associated with higher incidence of falls, indicating that NPS burden is an228
independent predictor for falls.229
The use of psychotropic medication in our study population was very high in all groups. However,230
there were significant differences in the number of psychotropics used in each NPS group. The231
group with highest NPS burden also had the highest number of psychotropics (2.3), compared with232
the groups with low NPS burden (2.1) and no significant NPS (1.8). Several earlier studies suggest233
that psychotropic medication use increases the risk of falls.36-38 To gain more insight into this234
relationship, we looked at the differences in fall rates among residents with and without235
psychotropic drug use. In our study, only NPI level was associated with incidence rate of falls,236
psychotropic drug use was not. There was no interaction indicating that psychotropic drug use did237
not modify this relationship. Our study suggests that in this special long-term population with238
severe cognitive impairment, the NPS burden is more important in determining falls than239
psychotropic drug use.240
In our study one-third of all falls during the one-year follow-up led to fall related negative241
consequences (20% to injuries, 7% to hospitalizations, 3% to fractures). This result is consistent242
with previous studies that have found that most falls do not result in injury. 4, 8, 20 Even though all243
falls do not lead to injury, every fall is significant as a previous fall is an important risk factor for244
another fall.39245
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Our study has some limitations that should be considered when interpreting the results. First, we did246
not ask about the use of physical restraints. It is well known that, despite clear evidence for a lack of247
effectiveness and safety, physical restraints are frequently used in nursing homes and their use is248
associated with falls.40-41 Another limitation is that only regularly used psychotropic medication was249
considered in our study. Psychotropics administered "pro re nata" may have had a different impact250
on falls and their consequences. Finally, as a longitudinal follow-up study of a special cohort, we251
cannot rule out unknown confounders having an effect on falls. Additionally we do not have data on252
past fall history.253
Our study has several strengths. The study sample is large and representative of older long-term254
care residents with cognitive impairment. We used many well-validated assessment instruments,255
and data were collected by trained study nurses resulting in high data validity. Another important256
strength is that, to our knowledge, no other study has previously examined the impact of severity of257
NPS on fall rate, nor has the association between NPS subgroups and fall rate or the interaction of258
severity of NPS and psychotropics with falls been investigated.259
Conclusions and Implications260
Most falls are not the result of a single cause, but occur due to an interaction of several risk factors.261
Thus, a multifactorial approach to fall prevention is recommended. The findings of this study262
indicate that evaluation of NPS, and especially severity of NPS, and NPS subgroups should be part263
of the comprehensive assessment when aiming to prevent falls in long-term care residents with264
cognitive impairment.265
266
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